Taken together, our study illustrates that irisin serves as a novel approach to inducing protective effect against myocardial dysfunction and insulin resistance in genetic diabetic model, which holds promise in developing a new therapeutic strategy in cardiac protection, diabetes, and obesity. Here, FNDC5 is linked to obesity due to melanocortin 4 receptor deficiency.